New painkiller cocktail could ease C-Section recovery
NCT ID NCT07072650
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 36 times
Summary
This study tested whether adding dexmedetomidine to a standard local anesthetic (bupivacaine) in a nerve block after C-section can improve pain relief. 80 women having planned C-sections took part. The goal was to see if the combination extends pain-free time, reduces recovery time, and lowers the need for extra pain medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE ANALGESIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bint Al-Huda Hospital/ thi qar office directorate
Nasiriyah, Thi Qar, 64001, Iraq
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexmedetomidine
What this could lead to
If it works, this could provide longer-lasting pain relief after C-sections with less need for additional painkillers.
What could go wrong
This is a small, early-phase trial with only 80 participants. Results may not apply to all patients, and the added drug could cause side effects like sedation.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.